EP2650380
Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function
:
EP einkaleyfi: Þýðing ekki lögð inn:
31.7.2008:
16.9.2015:
13167176.0
:
30.7.2028
:
Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function
31.7.2008
16.9.2015
:
Accera, Inc.:
380 Interlocken Crescent, Suite 780, 80021, Broomfield, Colorado, US
:
Henderson, Samuel T.:
Golden, CO, US
:
953074 P:
31.7.2007:
US
:
C12Q 1/68, G01N 33/48, A61K 31/12